VEGF 165b in the developing vasculatures of the fetal human eye

Developmental Dynamics

Volumn 241, Issue 3, 2012, Pages 595-607

  Baba, Takayuki ^a   Mcleod, D Scott ^a   Edwards, Malia M ^a   Merges, Carol ^a   Sen, Tanusree ^a   Sinha, Debasish ^a   Lutty, Gerard A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Angioblasts; Choroid; Endothelial cells; Pericytes; Retina; Vascular endothelial growth factor; Vasculogenesis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; UNCLASSIFIED DRUG; VASCULOTROPIN 165; VASCULOTROPIN 165 B;

ANGIOGENESIS; ARTICLE; CELL NUCLEUS; CHOROID CAPILLARY LAYER; CONTROLLED STUDY; EYE DEVELOPMENT; FETAL VITREOUS VASCULATURE; FETUS; FETUS DEVELOPMENT; GESTATION PERIOD; HEMANGIOBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MESENCHYMAL STEM CELL; NEUROBLAST; OCULAR BLOOD VESSEL; OPTIC NERVE FIBER; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINA; STAINING; STROMA CELL; TUNICA VASCULOSA LENTIS;

CELL NUCLEUS; FEMALE; FETAL DEVELOPMENT; FETUS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RETINA; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 84857047137     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.23743     Document Type: Article

References (49)

1. Baba T, Grebe R, Hasegawa T, Bhutto I, Merges C, McLeod DS, Lutty GA. 2009. Maturation of the fetal human choriocapillaris. Invest Ophthalmol Vis Sci 50: 3503-3511.
2. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. 1995. Embryonic stem cells express neuronal properties in vitro. Dev Biol 168: 342-357.
3. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ. 2002. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62: 4123-4131.
4. Bates D, Taylor GI, Minichiello J, Farlie P, Cichowitz A, Watson N, Klagsbrun M, Mamluk R, Newgreen DF. 2003. Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev Biol 255: 77-98.
5. Bhutto IA, Kim SY, McLeod DS, Merges C, Fukai N, Olsen BR, Lutty GA. 2004. Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci 45: 1544-1552.
6. Bhutto IA, McLeod DS, Hasegawa T, Kim SY, Merges C, Tong P, Lutty GA. 2006. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 82: 99-110.
7. Bocci G, Fasciani A, Danesi R, Viacava P, Genazzani AR, Del Tacca M. 2001. In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels. Mol Hum Reprod 7: 771-777.
8. Cai J, Jiang WG, Ahmed A, Boulton M. 2006. Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res 71: 20-31.
9. Chan-Ling T, Gock B, Stone J. 1995. The effect of oxygen on vasoformative cell division. Evidence that "physiological hypoxia" is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36: 1201-1214.
10. Cui TG, Foster RR, Saleem M, Mathieson PW, Gillatt DA, Bates DO, Harper SJ. 2004. Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein. Am J Physiol Renal Physiol 286: F767-773.
11. Fedtsova NG, Turner EE. 1995. Brn-3.0 expression identifies early post-mitotic CNS neurons and sensory neural precursors. Mech Dev 53: 291-304.
12. Ferrara N, Gerber HP, LeCouter J. 2003. The biology of VEGF and its receptors. Nat Med 9: 669-676.
13. Franco M, Roswall P, Cortez E, Hanahan D, Pietras K. 2011. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood 118: 2906-2917.
14. Hasegawa T, McLeod DS, Bhutto IA, Prow T, Merges CA, Grebe R, Lutty GA. 2007. The embryonic human choriocapillaris develops by hemo-vasculogenesis. Dev Dyn 236: 2089-2100.
15. Hasegawa T, McLeod DS, Prow T, Merges C, Grebe R, Lutty GA. 2008. Vascular precursors in developing human retina. Invest Ophthalmol Vis Sci 49: 2178-2192.
16. Herman IM. 1993. Actin isoforms. Curr Opin Cell Biol 5: 48-55.
17. Hua J, Spee C, Kase S, Rennel ES, Magnussen AL, Qiu Y, Varey A, Dhayade S, Churchill AJ, Harper SJ, Bates DO, Hinton DR. 2010. Recombinant human VEGF165b inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 51: 4282-4288.
18. Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA. 2006. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 12: 626-632.
19. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ. 2004. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35: 233-245.
20. Ladomery MR, Harper SJ, Bates DO. 2007. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm. Cancer Lett 249: 133-142.
21. Lutty GA, Merges C, Threlkeld AB, Crone S, McLeod DS. 1993a. Heterogeneity in localization of isoforms of TGF-b in human retina, vitreous, and choroid. Invest Ophthalmol Vis Sci 34: 477-487.
22. Lutty GA, Merges C, Threlkeld AB, Crone S, McLeod DS. 1993b. Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid. Invest Ophthalmol Vis Sci 34: 477-487.
23. Lutty GA, Hasegawa T, Baba T, Grebe R, Bhutto I, McLeod DS. 2010. Development of the human choriocapillaris. Eye (Lond) 24: 408-415.
24. Ma B, Sen T, Asnaghi L, Valapala M, Yang F, Hose S, McLeod DS, Lu Y, Eberhart C, Zigler J, Sinha D. 2011. bA3/A1-crystallin controls anoikis-mediated cell death in astrocytes by modulating PI3K/Akt/mTOR and ERK survival pathways. Cell Death Dis 2: e217.
25. Magnussen AL, Rennel ES, Hua J, Bevan HS, Long NB, Lehrling C, Gammons M, Floege J, Harper SJ, Agostini HT, Bates DO, Churchill AJ. 2010. VEGF-A165b is cytoprotective and antiangiogenic in the retina. Invest Ophthalmol Vis Sci 51: 4273-4281.
26. Marneros AG, Fan J, Yokoyama Y, Gerber HP, Ferrara N, Crouch RK, Olsen BR. 2005. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 167: 1451-1459.
27. McLeod DS, Hasegawa T, Prow T, Merges C, Lutty G. 2006. The initial fetal human retinal vasculature develops by vasculogenesis. Dev Dyn 235: 3336-3347.
28. Mhaskar R, Agarwal N, Takkar D, Buckshee K, Anandalakshmi, Deorari A. 1989. Fetal foot length: a new parameter for assessment of gestational age. Int J Gynaecol Obstet 29: 35-38.
29. Nowak DG, Woolard J, Amin EM, Konopatskaya O, Saleem MA, Churchill AJ, Ladomery MR, Harper SJ, Bates DO. 2008. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors. J Cell Sci 121: 3487-3495.
30. Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, Damodoran G, Hagiwara M, Harper SJ, Woolard J, Ladomery MR, Bates DO. 2010. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. J Biol Chem 285: 5532-5540.
31. Orlidge A, D'Amore PA. 1987. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105: 1455-1462.
32. Ozaki H, Yu AY, Della N, Ozaki K, Luna JD, Yamada H, Hackett SF, Okamoto N, Zack DJ, Semenza GL, Campochiaro PA. 1999. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 40: 182-189.
33. Perrin RM, Konopatskaya O, Qiu Y, Harper S, Bates DO, Churchill AJ. 2005. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia 48: 2422-2427.
34. Pritchard-Jones RO, Dunn DB, Qiu Y, Varey AH, Orlando A, Rigby H, Harper SJ, Bates DO. 2007. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer 97: 223-230.
35. Qiu Y, Hoareau-Aveilla C, Oltean S, Harper SJ, Bates DO. 2009. The anti-angiogenic isoforms of VEGF in health and disease. Biochem Soc Trans 37: 1207-1213.
36. Sadler JE. 1998. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67: 395-424.
37. Saint-Geniez M, Maldonado AE, D'Amore PA. 2006. VEGF expression and receptor activation in the choroid during development and in the adult. Invest Ophthalmol Vis Sci 47: 3135-3142.
38. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ, D'Amore PA. 2008. Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One 3: e3554.
39. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA. 2009. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA 106: 18751-18756.
40. Sheibani N, Frazier WA. 1998. Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol Biol Cell 9: 701-713.
41. Slomiany MG, Rosenzweig SA. 2006. Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J Pharmacol Exp Ther 318: 666-675.
42. Tomasek JJ, Haaksma CJ, Schwartz RJ, Vuong DT, Zhang SX, Ash JD, Ma JX, Al-Ubaidi MR. 2006. Deletion of smooth muscle alpha-actin alters blood-retina barrier permeability and retinal function. Invest Ophthalmol Vis Sci 47: 2693-2700.
43. Varey AH, Rennel ES, Qiu Y, Bevan HS, Perrin RM, Raffy S, Dixon AR, Paraskeva C, Zaccheo O, Hassan AB, Harper SJ, Bates DO. 2008. VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer 98: 1366-1379.
44. Walshe TE, Saint-Geniez M, Maharaj AS, Sekiyama E, Maldonado AE, D'Amore PA. 2009. TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS One 4: e5149.
45. Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, Cui TG, Sugiono M, Waine E, Perrin R, Foster R, Digby-Bell J, Shields JD, Whittles CE, Mushens RE, Gillatt DA, Ziche M, Harper SJ, Bates DO. 2004. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64: 7822-7835.
46. Yamagishi S, Kawakami T, Fujimori H, Yonekura H, Tanaka N, Yamamoto Y, Urayama H, Watanabe Y, Yamamoto H. 1999. Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Microvasc Res 57: 329-339.
47. Zhao J, Zhao M, Shi X, Liang J, Miao Y, Xie W, Zhang Y, Li X. 2011. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy. Exp Eye Res 93: 921-926.
48. Zhu M, Madigan MC, van Driel D, Maslim J, Billson FA, Provis JM, Penfold PL. 2000. The human hyaloid system: cell death and vascular regression. Exp Eye Res 70: 767-776.
49. Zigler JS, Zhang C, Grebe R, Sehrawat G, Hackler L, Adhya S, Hose S, McLeod DS, Bhutto I, Barbour W, Parthasarathy G, Zack DJ, Sergeev Y, Lutty GA, Handa JT, Sinha D. 2011. Mutation in the β-crystallin gene impairs phagosome degradation in the retinal pigment pithelium of rat. 2011. J Cell Sci 124: 523-552.